2006
DOI: 10.1017/s1355617706060991
|View full text |Cite
|
Sign up to set email alerts
|

Introduction—The changing view of neurorehabilitation: A new era of optimism

Abstract: Stroke is the leading health care problem requiring rehabilitation services today (CDC, 2001; Lee et al., 1996) with the worldwide incidence estimated to be between 300 and 500 per 100,000 people (Sudlow & Warlow, 1997). In most recent years, the rates of mortality are decreasing, resulting in a significant increase in the number of survivors living with the disabilities/handicaps associated with stroke (Thorvaldsen et al., 1997). Not only is stroke a common health problem, but the cognitive disorders th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…Thus, phase IV, a less formally organized effectiveness research phase, is devoted to assessing the impact of the drug as actually used in practice by more varied clinicians on more varied patients, and establishing differences in benefits and adverse effects among different patient subgroups, such as those with more comorbidities and complicating factors. 10,11 …”
Section: Clinical Research Proceeds In Phasesmentioning
confidence: 99%
“…Thus, phase IV, a less formally organized effectiveness research phase, is devoted to assessing the impact of the drug as actually used in practice by more varied clinicians on more varied patients, and establishing differences in benefits and adverse effects among different patient subgroups, such as those with more comorbidities and complicating factors. 10,11 …”
Section: Clinical Research Proceeds In Phasesmentioning
confidence: 99%
“…Randomised clinical trial (RCT) studies that are typically used to test the effectiveness of pharmaceutical treatments are not ideal for testing the efficacy of behavioural treatments in aphasia. Although this issue has been discussed at length elsewhere (e.g., Elman, 2006; Rothi & Barrett, 2006; Whyte, Gordon, & Rothi, 2009), there are several arguments against the use of RCTs that are worth noting because of their relevance to single-case study research. As noted by Rothi and Barrett (2006) and Whyte et al (2009), the emphasis on RCTs for rehabilitation research minimises the value of single case-studies to establish “proof of concept”.…”
mentioning
confidence: 99%
“…We are now entering an exciting period in poststroke care in which the time span and extent of continued improvement is extending incredibly. In another recent publication, we commented on the "new era of optimism" for cognitive recovery and poststroke cognitive rehabilitation [11]. An attitude of hope and expectation in stroke rehabilitation is likely to benefit survivors and families in and of itself.…”
mentioning
confidence: 99%